Piper Jaffray analyst William Quirk says his eBay (EBAY) channel checks suggest Hologic’s (HOLX) positive trends in his earlier research have reversed with more used Cynosure lasers hitting third party websites and prices trending down. While Cynosure represents just ~10% of Hologic’s total revenue, it carries a “heavy psychological burden on the share price,” Quirk tells investors in a research note. He maintains an Overweight rating on Hologic with a $49 price target, but recognizes the company’s March quarter results may bring a better entry point if his checks prove accurate.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.